These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28195831)

  • 21. Diagnostic criteria for cannabis withdrawal syndrome.
    Gorelick DA; Levin KH; Copersino ML; Heishman SJ; Liu F; Boggs DL; Kelly DL
    Drug Alcohol Depend; 2012 Jun; 123(1-3):141-7. PubMed ID: 22153944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychometric properties of the Cannabis Abuse Screening Test in Hungarian samples of adolescents and young adults.
    Gyepesi A; Urbán R; Farkas J; Kraus L; Piontek D; Paksi B; Horváth G; Magi A; Eisinger A; Pilling J; Kökönyei G; Kun B; Demetrovics Z
    Eur Addict Res; 2014; 20(3):119-28. PubMed ID: 24217457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How to screen for problematic cannabis use in population surveys: an evaluation of the Cannabis Use Disorders Identification Test (CUDIT) in a Swiss sample of adolescents and young adults.
    Annaheim B; Rehm J; Gmel G
    Eur Addict Res; 2008; 14(4):190-7. PubMed ID: 18583916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An improved brief measure of cannabis misuse: the Cannabis Use Disorders Identification Test-Revised (CUDIT-R).
    Adamson SJ; Kay-Lambkin FJ; Baker AL; Lewin TJ; Thornton L; Kelly BJ; Sellman JD
    Drug Alcohol Depend; 2010 Jul; 110(1-2):137-43. PubMed ID: 20347232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of perceived social support on quality of life in Turkish men with alcohol, opiate and cannabis use disorder.
    Ates N; Unubol B; Bestepe EE; Bilici R
    J Ethn Subst Abuse; 2023; 22(2):316-336. PubMed ID: 31686619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validity and reliability of short forms of parental-caregiver perception and family impact scale in a Telugu speaking population of India.
    Kumar S; Kroon J; Lalloo R; Johnson NW
    Health Qual Life Outcomes; 2016 Mar; 14():34. PubMed ID: 26932786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabis and the brain.
    Castle DJ; Ames FR
    Aust N Z J Psychiatry; 1996 Apr; 30(2):179-83. PubMed ID: 8811260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychometric properties of the Turkish version of the Internet Addiction Test (IAT).
    Boysan M; Kuss DJ; Barut Y; Ayköse N; Güleç M; Özdemir O
    Addict Behav; 2017 Jan; 64():247-252. PubMed ID: 26421905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Motivations for cannabis cessation, coping and adaptation strategies, and perceived benefits: impact on cannabis use relapse and abstinence].
    Chauchard E; Septfons A; Chabrol H
    Encephale; 2013 Dec; 39(6):385-92. PubMed ID: 23928064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic cannabinoid use among college students.
    Mathews EM; Jeffries E; Hsieh C; Jones G; Buckner JD
    Addict Behav; 2019 Jun; 93():219-224. PubMed ID: 30772774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short scales to assess cannabis-related problems: a review of psychometric properties.
    Piontek D; Kraus L; Klempova D
    Subst Abuse Treat Prev Policy; 2008 Dec; 3():25. PubMed ID: 19055741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
    Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
    Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translation and validation of the French version of the Child Perceptions Questionnaire for children aged from 8 to 10 years old (CPQ
    Boy-Lefèvre ML; Razanamihaja N; Azogui-Lévy S; Vigneron A; Jordan L; Berdal A; de la Dure-Molla M
    Health Qual Life Outcomes; 2018 May; 16(1):86. PubMed ID: 29720198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between personality disorders traits and problematic cannabis use in adolescents.
    Chabrol H; Melioli T; Goutaudier N
    Subst Use Misuse; 2015 Apr; 50(5):552-6. PubMed ID: 25496169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A preliminary evaluation of synthetic cannabinoid use among adolescent cannabis users: Characteristics and treatment outcomes.
    Blevins CE; Banes KE; Stephens RS; Walker DD; Roffman RA
    Addict Behav; 2016 Dec; 63():114-9. PubMed ID: 27454353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug use disorder (DUD) questionnaire: scale development and validation.
    Scherer M; Furr-Holden CD; Voas RB
    Eval Rev; 2013 Feb; 37(1):35-58. PubMed ID: 23711632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Contributions of parental and social influences to cannabis use in a non-clinical sample of adolescents].
    Chabrol H; Mabila JD; Chauchard E; Mantoulan R; Rousseau A
    Encephale; 2008 Jan; 34(1):8-16. PubMed ID: 18514145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the validity of the CUDIT-R in a subpopulation of cannabis users.
    Loflin M; Babson K; Browne K; Bonn-Miller M
    Am J Drug Alcohol Abuse; 2018; 44(1):19-23. PubMed ID: 29058471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of cognitive functions in individuals with synthetic cannabinoid use disorder and comparison to individuals with cannabis use disorder.
    Cengel HY; Bozkurt M; Evren C; Umut G; Keskinkilic C; Agachanli R
    Psychiatry Res; 2018 Apr; 262():46-54. PubMed ID: 29407568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychometric properties of the CAST and SDS scales in young adult cannabis users.
    Cuenca-Royo AM; Sánchez-Niubó A; Forero CG; Torrens M; Suelves JM; Domingo-Salvany A
    Addict Behav; 2012 Jun; 37(6):709-15. PubMed ID: 22386300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.